These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 36481719)
21. Quantitative Measurement of Metal Accumulation in Brain of Patients With Wilson's Disease. Li G; Wu R; Tong R; Bo B; Zhao Y; Gillen KM; Spincemaille P; Ku Y; Du Y; Wang Y; Wang X; Li J Mov Disord; 2020 Oct; 35(10):1787-1795. PubMed ID: 32681698 [TBL] [Abstract][Full Text] [Related]
22. Metal deposits associated with brain atrophy in the deep gray matter nucleus in Wilson's disease. Huang Z; Yang J; Chen D; Zhou X; Xiao X; Wang J; Wang M; Zhao J; Chu J Cereb Cortex; 2023 Jul; 33(15):9223-9232. PubMed ID: 37365842 [TBL] [Abstract][Full Text] [Related]
23. Changes in brain susceptibility in Wilson's disease patients: a quantitative susceptibility mapping study. Deng W; Zhang J; Yang J; Wang Z; Pan Z; Yue X; Zhao R; Qian Y; Yu Y; Li X Clin Radiol; 2024 Feb; 79(2):e282-e286. PubMed ID: 38087682 [TBL] [Abstract][Full Text] [Related]
24. Dysfunction of the Lenticular Nucleus Is Associated with Dystonia in Wilson's Disease. Yang Y; Wei T; Yang W; Hu S; Jiang H; Dong W; Hao W; Yang Y; Qian N; Ding Y Brain Sci; 2022 Dec; 13(1):. PubMed ID: 36671989 [TBL] [Abstract][Full Text] [Related]
25. A study of neurite orientation dispersion and density imaging in wilson's disease. Song YK; Li XB; Huang XL; Zhao J; Zhou XX; Wang YL; Yan X; Wang JY; Chu JP J Magn Reson Imaging; 2018 Aug; 48(2):423-430. PubMed ID: 29251804 [TBL] [Abstract][Full Text] [Related]
26. Microstructural and functional impairment of the basal ganglia in Wilson's disease: a multimodal neuroimaging study. Su D; Zhang Z; Zhang Z; Gan Y; Zhang Y; Liu X; Bi J; Ma L; Zhao H; Wang X; Wang Z; Ma H; Sifat S; Zhou J; Li W; Wu T; Jing J; Feng T Front Neurosci; 2023; 17():1146644. PubMed ID: 37152597 [TBL] [Abstract][Full Text] [Related]
27. Neuroimaging correlates of brain injury in Wilson's disease: a multimodal, whole-brain MRI study. Shribman S; Bocchetta M; Sudre CH; Acosta-Cabronero J; Burrows M; Cook P; Thomas DL; Gillett GT; Tsochatzis EA; Bandmann O; Rohrer JD; Warner TT Brain; 2022 Mar; 145(1):263-275. PubMed ID: 34289020 [TBL] [Abstract][Full Text] [Related]
28. Study on Lesion Assessment of Cerebello-Thalamo-Cortical Network in Wilson's Disease with Diffusion Tensor Imaging. Wang A; Wu H; Xu C; Tang L; Lee J; Wang M; Jiang M; Li C; Lu Q; Zhang C Neural Plast; 2017; 2017():7323121. PubMed ID: 28781902 [TBL] [Abstract][Full Text] [Related]
29. Diffusion tensor imaging of the extracorticospinal network in the brains of patients with Wilson disease. Zhou XX; Li XH; Qin H; Li GD; Huang HW; Liang YY; Liang XL; Pu XY J Neurol Sci; 2016 Mar; 362():292-8. PubMed ID: 26944166 [TBL] [Abstract][Full Text] [Related]
30. Susceptibility-Weighted Imaging Manifestations in the Brain of Wilson's Disease Patients. Yang J; Li X; Yang R; Yu X; Yu C; Qian Y; Yu Y PLoS One; 2015; 10(4):e0125100. PubMed ID: 25915414 [TBL] [Abstract][Full Text] [Related]
31. Diffusion tensor imaging (DTI) and its clinical correlates in drug naïve Wilson's disease. Jadav R; Saini J; Sinha S; Bagepally B; Rao S; Taly AB Metab Brain Dis; 2013 Sep; 28(3):455-62. PubMed ID: 23636656 [TBL] [Abstract][Full Text] [Related]
32. Magnetic Susceptibility Changes in the Basal Ganglia and Brain Stem of Patients with Wilson's Disease: Evaluation with Quantitative Susceptibility Mapping. Doganay S; Gumus K; Koc G; Bayram AK; Dogan MS; Arslan D; Gumus H; Gorkem SB; Ciraci S; Serin HI; Coskun A Magn Reson Med Sci; 2018 Jan; 17(1):73-79. PubMed ID: 28515413 [TBL] [Abstract][Full Text] [Related]
33. Deep-gray nuclei susceptibility-weighted imaging filtered phase shift in patients with Wilson's disease. Bai X; Wang G; Wu L; Liu Y; Cui L; Shi H; Guo L Pediatr Res; 2014 Mar; 75(3):436-42. PubMed ID: 24477071 [TBL] [Abstract][Full Text] [Related]
34. Brain volume is related to neurological impairment and to copper overload in Wilson's disease. Smolinski L; Litwin T; Redzia-Ogrodnik B; Dziezyc K; Kurkowska-Jastrzebska I; Czlonkowska A Neurol Sci; 2019 Oct; 40(10):2089-2095. PubMed ID: 31147855 [TBL] [Abstract][Full Text] [Related]
35. Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series. De Fabregues O; Viñas J; Palasí A; Quintana M; Cardona I; Auger C; Vargas V Brain Behav; 2020 May; 10(5):e01596. PubMed ID: 32202078 [TBL] [Abstract][Full Text] [Related]
36. Impact of treatment on blood-brain barrier impairment in Wilson's disease. Misztal M; Członkowska A; Cudna A; Palejko A; Litwin T; Piechal A; Kurkowska-Jastrzębska I Neurol Neurochir Pol; 2023; 57(4):379-386. PubMed ID: 37526174 [TBL] [Abstract][Full Text] [Related]
37. Neuroimaging Correlates of Cognitive Deficits in Wilson's Disease. Shribman S; Burrows M; Convery R; Bocchetta M; Sudre CH; Acosta-Cabronero J; Thomas DL; Gillett GT; Tsochatzis EA; Bandmann O; Rohrer JD; Warner TT Mov Disord; 2022 Aug; 37(8):1728-1738. PubMed ID: 35723521 [TBL] [Abstract][Full Text] [Related]
38. Inhibitory rTMS applied on somatosensory cortex in Wilson's disease patients with hand dystonia. Lozeron P; Poujois A; Meppiel E; Masmoudi S; Magnan TP; Vicaut E; Houdart E; Guichard JP; Trocello JM; Woimant F; Kubis N J Neural Transm (Vienna); 2017 Oct; 124(10):1161-1170. PubMed ID: 28689295 [TBL] [Abstract][Full Text] [Related]
39. Corpus callosum abnormalities in Wilson's disease. Trocello JM; Guichard JP; Leyendecker A; Pernon M; Chaine P; El Balkhi S; Poupon J; Chappuis P; Woimant F J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1119-21. PubMed ID: 20660913 [TBL] [Abstract][Full Text] [Related]
40. Wilson's disease tremor is associated with magnetic resonance imaging lesions in basal ganglia structures. Südmeyer M; Saleh A; Wojtecki L; Cohnen M; Gross J; Ploner M; Hefter H; Timmermann L; Schnitzler A Mov Disord; 2006 Dec; 21(12):2134-9. PubMed ID: 17044091 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]